首页> 中文期刊> 《中国继续医学教育》 >子宫肌瘤患者采用腹腔镜子宫肌瘤剔除术联合子宫动脉阻断术的临床应用

子宫肌瘤患者采用腹腔镜子宫肌瘤剔除术联合子宫动脉阻断术的临床应用

         

摘要

Objective To study the clinical effect of uterine leiomyoma patients using laparoscopic myomectomy and uterine arterial blocking combination therapy. Methods Chose 60 cases of uterine ifbroids methods in our hospital from 2010 to 2012, divided into the observation group and the control group, the control group took the laparoscopic myomectomy, observation group was using myomectomy and uterine artery occlusion combined treatment, compared treatment effect in two groups of patients. Results After treatment, clinical bleeding rate volume and complications in the observation group were lower than the control group, during postoperative follow-up periods, in the ifrst half of the year, 1 years, 2 year recurrence rate, the observation group were lower than the control group. Conclusion Laparoscopic myomectomy and uterine arterial blocking joint uterine fibroids treatment has better effect, less amount of bleeding than laparoscopic myomectomy.%目的:研究分析为子宫肌瘤患者使用腹腔镜子宫肌瘤剔除术和子宫动脉阻断术联合治疗的临床效果。方法对2010~2012年我院的60例子宫肌瘤患者来进行探讨分析,分为对照组和观察组两组,对照组采取腹腔镜子宫肌瘤剔除术,观察组使用子宫肌瘤剔除术和子宫动脉阻断术联合治疗,对两组患者的治疗效果进行比较。结果经过手术治疗后,观察组患者临床出血量和并发症几率均比对照组低,术后根据随访情况来看,在半年、1年、2年的复发率,观察组均比对照组低。结论腹腔镜子宫肌瘤剔除术和子宫动脉阻断术联合进行子宫肌瘤治疗具有比较好的效果,比单纯的腹腔镜子宫肌瘤剔除术的出血量要少,恢复速度更快,预后效果更好。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号